Ace Vision Group Adds Four Ophthalmologists to Medical Advisory Board; Launches New Corporate and Medical Affairs Websites
Ace Vision Group announced the addition of Cathleen McCabe, MD; James Katz, MD; Ehsan Sadri, MD; and Dagny Zhu, MD, to its medical advisory board. These prominent ophthalmologists will contribute expertise to advance the development and implementation of novel solutions for eye health, specifically Laser Scleral Microporation (LSM), a laser therapeutic designed to rejuvenate the eye’s natural Dynamic Range of Focus (DRoF) function.
Explore More Articles
Presbyopia treatment options now and on the horizon
The large number of patients worldwide with presbyopia creates a unique opportunity for eyecare providers to improve patients’ quality of life, according to George Waring IV, MD, FACS. There are more than 2.1 billion presbyopes worldwide. Dr. Waring noted the many implications of this large number, not just from a quality of life standpoint but …
read moreAce Vision Group to Host “Take the Presbyopia Challenge” Event and Present Scientific Posters at 2025 ASCRS Annual Meeting
BOSTON, April 10, 2025 (GLOBE NEWSWIRE) — Ace Vision Group, Inc. (“AVG” or “the Company”), an emerging medical device company on the forefront of pioneering a laser microporation therapy for the aging eye, today announced that it will host an event and multiple scientific presentations at the 2025 American Society of Cataract and Refractive Surgery (ASCRS) Annual …
read moreVIDEO: New laser offers further improvement to laser scleral microporation
BOSTON — In this Healio Video Perspective from Eyecelerator@ASCRS, AnnMarie Hipsley, DPT, PhD, and George O. Waring IV, MD, FACS, discuss the latest advances in laser scleral microporation.Hipsley said that the GenII VisioLite laser for laser scleral microporation (LSM) is on the pathway to commercialization and may be available by the end of the year.
read more